(+) and (À)-Dihydropinidine and (+)-and (À)-epidihydropinidine were synthesized from hydroxy esters 1 and 2 which had been prepared by yeast reduction of methyl (2-oxocyclohexyl)acetate. The enantiomeric excess at the C-1 positions of 1 and 2 were both determined as more than 99% ee.
Yeast reduction of methyl (2-oxocyclohexyl) acetate, which gives hydroxy ester 1 (98% ee) and 2 (97%ee), has been previously reported (Fig. 1) .
1) The purpose of this work is to recheck the enantiomeric excess at the C-1 positions of 1 and 2 and to apply these yeast-mediated reduction products to the syntheses of natural products. Ring opening of 1 and 2 would give useful chiral synthons.
(+)-and (À)-Dihydropinidine (3) and (+)-and (À)-epidihydropinidine (4) were selected as the target compounds. Dihydropinidine was isolated from the Mexican bean beetle, Epilachna varivestis, 2) and epidihydropinidine was isolated from Pinus engelmannii.
3)
Many reports of syntheses of (+)-and (À)-dihydropinidine have been published, due to biological activity (necrotoxic, hemolytic, phytotoxic, insecticidal, antibacterial, and antifungal) 4) of 2,6-disubstituted piperidine. Two of these employed the enzymatic pathway. 5, 6) T. Momose et al. have obtained enantiomerically pure starting materials to (+)-and (À)-dihydropinidine. 5) R. Chênevert et al. have obtained only (+)-dihydropinidine from the enantiomerically pure starting material. 6) In both these reports, lipase has been employed to produce enantiomerically pure material. In the case of epidihydropinidine, only two synthetic pathways to (+)-epidihydropinidine have been reported. 7, 8) However, these seems to have been no synthetic research of (À)-epidihydropinidine. This article describes the syntheses of (+)-and (À)-dihydropinidine and (+)-and (À)-epidihydropinidine by using yeast reduction of methyl (2-oxocyclohexyl) acetate. This is a first approach to get both the (+) and (À) isomers of dihydropinidine and epidihydropinidine from one racemic compound by employing baker's yeast. This is also the first synthetic report on (À)-epidihydropinidine.
The synthetic plan is shown in Scheme 1. The piperidine ring of (À)-3 and (+)-4 would be formed by S N 2 cyclization of 5 and 7, respectively. Compounds 6 and 8 could be respectively transformed to 5 and 7 via stereoselective -hydroxylation followed by S N 2 conversion to an amino group. Both compounds 6 and 8 would be obtained from lactone 9 by ring opening and C-C bond elongation. Lactone 9 could be obtained from yeast-mediated reduction product 1, and (+)-dihydropinidine (3) and (À)-epidihydropinidine (4) could be synthesized from yeast-mediated reductive product 2. The C-1 positions of 1 and 2 would be respectively converted to the C-6 positions of 3 and 4. This means that the values for the enantiomeric excess at the C-6 positions of 3 and 4 would depend on that at the C-1 positions of 1 and 2. The chiral center at the C-2 positions of 3 and 4 would be introduced by using Evans's chiral auxiliaries.
9)

Results and Discussion
Hydroxy ester 1 was subjected to LiAlH 4 reduction followed by protection of the resulting primary hydroxy y To whom correspondence should be addressed. Fax: +81-89-977-4364; E-mail: syamauch@agr.ehime-u.ac.jp group as a TBDPS ether by using TBDPSCl and imidazole (53% yield, 2 steps). After PCC oxidation of cyclohexanol derivative 10 (95% yield), resulting ketone 11 was converted to lactone 12 by BaeyerVilliger oxidation, employing MCPBA in a phosphate buffer at pH 8 and CHCl 3 , 10) in 98% yield. The enantiomeric excess was determined after methanolysis of this lactone 12. (R)-Hydroxy ester 13 was reacted with (À)-menthyl chloroformate, and the product was determined as being of more than 99% de by an HPLC analysis. On the other hand, corresponding (S)-hydroxy ester 13, which had been transformed from yeast-mediated reduction product 2 by the same process, was also determined as being of more than 99% de. It became clear that the enantiomeric excess at the C-1 positions of yeast-mediated reduction products 1 and 2 were more than 99% ee, and that Baeyer-Villiger oxidation had proceeded with complete retention of the configuration.
After protecting of the secondary hydroxy group as an MOM ether by using MOMCl and N,N-diisopropylethylamine in 95% yield, the silyl group was removed by (n-Bu) 4 NF to give alcohol 15 in 94% yield. After conversion to a tosylate (95% yield), C-C bond elongation was accomplished by employing Me 2 CuLi, giving 16 in 78% yield. Hydrolysis of 16 (98% yield) followed by introduction of the S or R Evans's chiral auxiliary 11) gave 18 in 93% yield and 25 in 97% yield, respectively. The -hydroxylation of 18 and 25 by using MoOPH 12) stereoselectively proceeded to give 19 (43% yield, 17% recovered) and 26 (45% yield, 18% recovered), respectively. In both reactions, 18 and 25 were recovered. The auxiliaries were reductively removed by using LiBH 4 to give glycols 20 (79% yield) and 27 (84% yield), respectively. These glycols were converted to monotosylates by using TsCl and pyridine, which were subsequently treated with LiAlH 4 to give 21 (66% yield, 2 steps) and 28 (73% yield, 2 steps), respectively. After the secondary hydroxy groups had been converted to mesylates by using MsCl and Et 3 N, the resulting mesylates were treated with NaN 3 to give azides 22 (85% yield, 2 steps) and 29 (91% yield, 2 steps), respectively. To remove the MOM ethers, 22 and 29 were each treated with a diluted aqueous HCl solution, giving alcohol 23 (95% yield) and 30 (95% yield), respectively. After their conversion to mesylates, S N 2 cyclization was performed by treatment with Ph 3 P in heated aqueous THF. The crude products were respectively transformed to Cbz-form 24 (42% yield, 3 steps) and 31 (44% yield, 3 steps) by using CbzCl in an aqueous K 2 CO 3 solution and THF for purification. Finally, removal of the Cbz groups by H 2 and Pd(OH) 2 / C followed by treatment with an aqueous HCl solution gave (À)-3 (78% yield) and (+)-4 (98% yield), respectively. By the same synthetic process, (+)-3 and (À)-4 were respectively synthesized from yeast-mediated reduction product 2 (Scheme 2).
The enantiomeric excess at the C-1 positions of yeastmediated reduction products 1 and 2 were determined as more than 99% ee. 
Experimental
Melting point (mp) data are uncorrected. NMR data were measured by a JNM-EX400 spectrometer, IR spectra were determined with a Shimadzu FTIR-8100 spectrophotometer, FABMS data were measured with a JMS-MS700V spectrometer, and optical rotation values were evaluated with a HORIBA SEPA-200 instrument. The silica gel used was Wakogel C-300 (Wako, 200-300 mesh). HPLC analyses were performed with Shimadzu LC-6AD and SPD-6AV instruments.
(1S,2R)-2-[2-(tert-Butyldiphenylsilyloxy)ethyl]cyclohexanol (10) . To an ice-cooled suspension of LiAlH 4 (2.04 g, 0.054 mol) in ether (20 ml) was added a solution of trans-hydroxy ester 1 (10.1 g, 0.059 mol) in ether (50 ml). After stirring at 0 C for 1 h, sat. aq. MgSO 4 solution and K 2 CO 3 were added. The mixture was stirred for 30 min before filtration. The filtrate was concentrated to give crude diol. A reaction solution of crude diol, tert-butyldiphenylsilyl chloride (15.3 ml, 0.059 mol) and imidazole (8.01 g, 0.12 mol) in DMF (2 ml) was stirred at room temperature for 2 h before additions of sat. aq. NaHCO 3 solution and ethyl acetate. The organic solution was separated, washed with brine, and dried (Na 2 SO 4 ). After the organic solution was concentrated, the residue was applied to silica gel column chromatography (5% EtOAc in hexane) to give silyl ether 10 (11.7 g, 0.031 mol, 53%) as a colorless oil, ½ 1, 24.9, 25.7, 26.8, 32.2, 35.1, 37.3, 44.3, 63.3, 74.7, 127.7, 129.7, 133.2, 135.6 (10) . By the same method as that described for the preparation of (1S,2R)-10, the title 1, 20.7, 25.1, 26.8, 27.1, 32.7, 34.8, 39.0, 62.4, 69.1, 127.7, 129.7, 133.5, 133.6, 135.56, 135.59 1, 26.9, 28.1, 32.1, 34.0, 42.1, 47.1, 61.7, 127.6, 129.6, 133.9, 134.0, 135.5, 213 (R)-8-(tert-Butyldiphenylsilyloxy)octan-6-olide (12) . A reaction mixture of (R)-ketone 11 (20.4 g, 0.054 mol) and MCPBA (16.4 g, 70%, 0.067 mol) in CHCl 3 (200 ml) and phosphate buffer pH 8 (200 ml) was stirred at room temperature for 14 h. After filtration, the filtrate was washed with sat. aq. sodium thiosulfate solution, sat. aq. NaHCO 3 solution, and brine, and dried (Na 2 SO 4 ). The organic solution was evaporated, and then the residue was applied to silica gel column chromatography (5% EtOAc/hexane) to give lactone 12 (21.0 g, 0.053 mol, 98%) as colorless crystals, mp 60-61 3000, 2934, 1721, 1429, 1329, 1287, 1258, 1177, 1148, 1113, 1082, 1014 3.75 (1H, ddd, J 10.5, 4.9, 4.9 Hz, 3.87 (1H, ddd, J 10.5, 8.6, 4.4 Hz, 4.54 (1H, m, m, ArH), m, ArH) . NMR C (CDCl 3 ): 19. 2, 23.0, 26.9, 28.3, 34.5, 34.8, 39.0, 59.8, 77.0, 127.69, 127.72, 129.7, 133.5, 133.7, 135.5, 175.6 (R)-Methyl 8-tert-butyldiphenylsilyloxy-6-hydroxyoctanoate (13) . A reaction mixture of (R)-lactone 12 (22.7 g, 0.057 mol) and K 2 CO 3 (7.91 g, 0.057 mol) in MeOH (150 ml) was stirred at room temperature for 1 h before concentration. The residue was dissolved in EtOAc and H 2 O. The organic solution was separated, washed with brine, and dried (Na 2 SO 4 ). After the organic solution was evaporated, the residue was applied to silica gel column chromatography (EtOAc/hexane = 1/5) to give (R)-methyl ester 13 (23.8 g, 0.056 0, 25.0, 25.2, 26.8, 34.1, 37.1, 38.3, 51.5, 63.6, 71.6, 127.8, 129.8, 132.9, 133.0, 135.5, 135.6, 174 Determination of the optical purity of the (R)-and (S)-methyl esters (13) . To an ice-cooled solution of (R)-13 (28 mg, 0.065 mmol) in pyridine (50 l) was added (À)-menthyl chloroformate (20.9 l, 0.098 mmol). After the reaction mixture was stirred at room temperature for 1 h, H 2 O and EtOAc were added. The organic solution was separated, washed with 0.5 M aq. HCl solution and sat. aq. NaHCO 3 solution, and brine, and dried (Na 2 SO 4 ). The organic solution was concentrated. The residue was applied to HPLC (Merck, LiChrospher Si 60, 2% EtOAc in hexane, 2.0 ml/min, detected at 270 nm), retention time: 22 min, more than 99% de. Reaction product of (S)-13 with (À)-menthyl chloroformate: 19 min, more than 99% de.
t., 14 h (98%). (d) K
(R)- . A reaction mixture of (R)-alcohol 13 (23.8 g, 0.056 mol), (iso-Pr) 2 EtN (38.7 ml, 0.22 mol), and MOMCl (8.43 ml, 0.11 mol) 8, 25.1, 26.9, 34.0, 34.4, 37.3, 51.4, 55.5, 60.6, 74.7, 95.7, 127.6, 129.6, 133.9, 135.6, 
(S)-Methyl 6-methoxymethoxynonanoate (16).
A reaction mixture of (R)-alcohol 15 (4.55 g, 0.019 mol), pTsCl (3.70 g, 0.019 mol) and pyridine (3.14 ml, 0.039 mol) in CH 2 Cl 2 (8 ml) was stirred at room temperature for 12 h before additions of H 2 O and CH 2 Cl 2 . The organic solution was separated, washed with 1 M aq. HCl solution, sat. aq. NaHCO 3 solution, and brine, and dried (Na 2 SO 4 ). The organic solution was evaporated, and then the residue was applied to silica gel column chromatography (10% EtOAc in hexane) to give unstable tosylate (7.15 g, 0. 018 mol, 95%) as a colorless oil. To a suspension of CuI (14.0 g, 0.074 mol) in ether (15 ml) was added MeLi (66.9 ml, 2.2 M in ether, 0.15 mol) at À40 C. After the mixture was stirred at À40 C for 2 h, tosylate (7.15 g, 0.018 mol) in ether (20 ml) was added. The reaction mixture was stirred at À40 C for 2.5 h, and then sat. aq. NH 4 Cl solution and ether were added. The organic solution was separated, washed with brine, and dried (Na 2 SO 4 ). After concentration, the residue was purified with silica gel column chromatography (10% EtOAc in hexane) to recover tosylate (1.56 g, 0.0040 mol, 22%) 2, 18.5, 24.8, 25.1, 33.9, 34.0, 36.5, 51.4, 55.5, 77.1, 95.4, 174 (S)-6-Methoxymethoxynonanoic acid (17). A reaction solution of (S)-ester 16 (10.1 g, 0.043 mol) in 6 M aq. KOH solution (100 ml) and EtOH (100 ml) was stirred at room temperature for 2 h before additions of CHCl 3 and 6 M aq. HCl solution. The organic solution was separated, washed with brine, and dried (Na 2 SO 4 ). After the organic solution was evaporated, the residue was applied to silica gel column chromatography (EtOAc/hexane = 1/2) to give carboxylic acid 17 (9.17 2, 18.5, 24.7, 24.8, 33.9, 36.5, 55.5, 77.1, 95.4, 179.4 
(4S)-4-Benzyl-3-[(S)-6-methoxymethoxynonanoyl]-2-oxazolidinone (18).
To a solution of (S)-carboxylic acid 17 (6.57 g, 0.030 mol) and Et 3 N (4.41 ml, 0.032 mol) in THF (150 ml) was added PivCl (3.89 ml, 0.032 mol) at À70 C. The mixture was stirred at 0 C for 1 h before cooling to À70 C. To this mixture was added lithium salt of (S)-4-benzyl-2-oxazolidinone, which was prepared with (S)-4-benzyl-2-oxazolidinone (5.60 g, 0.032 mol) and n-BuLi (20.1 ml, 1.6 M in hexane, 0.032 mol) in THF (150 ml) at À70 C for 30 min. After the resulting reaction mixture was stirred at 0 C for 30 min, sat. aq. NH 4 Cl solution was added. The organic solution was separated, washed with brine, and dried (Na 2 SO 4 ). The organic solution was evaporated, and then the residue was applied to silica gel column chromatography (10% EtOAc in hexane) to give acyl oxazolidinone 18 (10.7 g, 0.028 mol, 93%) as colorless crystals, mp 60-61 C (iso- 2934, 1782, 1700, 1385, 1352, 1210, 1200, 1150, 1098, 1038 cm À1 . NMR H (CDCl 3 ): 0.92 (3H, s, J 7.1 Hz, CH 3 ), 1.30-1.58 (8H, m), 1.62-1.74 (2H, m), 2.77 (1H, dd, J 13.4, 9.5 Hz, PhCHH), 2.85-3.00 (2H, m, O=CCH 2 ), 3.34 (1H, dd, J 13.4, 3.1 Hz, PhCHH), 3.38 (3H, s, OCH 3 ), 3.55 (1H, m, CHOMOM), 4.16 (1H, dd, J 8.8, 3.4 Hz, 4.20 (1H, dd, J 8.8, 8.8 Hz, 5-HH), 4.65 (2H, s, OCH 2 OCH 3 ), m, m, ArH), m, ArH), m, ArH) . NMR C (CDCl 3 ): 14. 3, 18.5, 24.4, 24.8, 34.1, 35.5, 36.6, 37.9, 55.5, 66.2, 77.1, 77.2, 95.4, 127.3, 128.9, 129.4, 135.3, 153.4, 173.2. Anal. Found: C, 66.75; H, 8.19; N, 3. (4S)-4-Benzyl-3-[(2S,6S)-2-hydroxy-6-methoxymethoxynonanoyl]-2-oxazolidinone (19). To a solution of (4S)-[(S)]-18 (10.7 g, 0.028 mol) in THF (300 ml) was added KHMDS (84.9 ml, 0.5 M in toluene, 0.042 mol) at À70 C. After stirring at À70 C for 30 min, MoOPH (18.5 g, 0.043 mol) was added. The reaction mixture was stirred at À70 C for 2 h, and then sat. aq. Na 2 SO 3 solution was added. The organic solution was separated, washed with 1 M aq. HCl solution, sat. aq. NaHCO 3 solution, and brine, and dried (Na 2 SO 4 ). After evaporation, the residue was applied to silica gel column chromatography (10% EtOAc in hexane) to give ( , 2934, 1788, 1694, 1385, 1352, 1298, 1213, 1198, 1150, 1111, 1098, 1038, 912 2, 18.5, 21.1, 33.9, 34.3, 36.6, 37.5, 55.5, 66.9, 70.6, 70.8, 77.2, 95.5, 127.5, 129.0, 129.4, 134.8, 153.2, 174.9 . Anal. 3.44 (1H, dd, J 10.7, 7.3 Hz, 3.55 (1H, m, 3.65 (1H, dd, J 10.7, 2.9 Hz, 3.70 (1H, m, 4.65 (2H, s, OCH 2 OCH 3 ) . NMR C (CDCl 3 ): 14. 2, 18.5, 21.1, 33.2, 34.2, 36.6, 55.5, 66.7, 72.1, 95.5. Anal. Found: C, 59.69; H, 11.01. Calcd. (2R,6S)-6-Methoxymethoxy-2-nonanol (21). To an ice-cooled solution of (2S,6S)-glycol 20 (1.34 g, 6.08 mmol) and pyridine (0.98 ml, 12.1 mmol) 2, 18.5, 21.3, 23.5, 34.2, 36.5, 39.4, 55.5, 68.0, 77.3, 95.4 (2S,6S)-2-Azido-6-methoxymethoxynonane (22). To a solution of (2R,6S)-alcohol 21 (0.81 g, 3.96 mmol) and Et 3 N (0.61 ml, 4.38 mmol) in CH 2 Cl 2 (5 ml) was added MsCl (0.34 ml, 4.39 mmol). The reaction mixture was stirred at room temperature for 1.5 h before additions of H 2 O and CH 2 Cl 2 . The organic solution was separated, washed with brine, and dried (Na 2 SO 4 ). After concentration, the residue was purified with silica gel column chromatography (EtOAc/hexane = 1/4) to give unstable mesylate (1.00 g, 3.54 mmol, 89%) as a colorless oil. A reaction solution of mesylate (1.00 g, 3.54 mmol) and NaN 3 (0.46 g, 7. 08 mmol) in DMF (1 ml) was stirred at 100 C for 1 h before additions of H 2 O and EtOAc. The organic solution was separated, washed with brine, and dried (Na 2 SO 4 ). The solvent was evaporated. The residue was applied to silica gel column chromatography (5% EtOAc in hexane) to give (2S,6S 2, 18.5, 19.4, 21.9, 34.1, 36.4, 36.6, 55.5, 58.0, 77.1, 95.5. Anal. Found: C, 57.65; H, 10.12; N, 18.21 3.44 (1H, m, 8-H), 3.61 (1H, m, 4-H) . NMR C (CDCl 3 ): 14. 1, 18.8, 19.4, 22.3, 36.2, 37.1, 39.7, 58.0, 71.5. Anal. Found: C, 58.30; H, 10.40; N, 22.58 (2S,6R)-1-Benzyloxycarbonyl-2-methyl-6-propylpiperidine (24). To an ice-cooled solution of (4S,8S)-alcohol 23 (0.60 g, 3.24 mmol) and Et 3 N (0.50 ml, 3.59 mmol) in CH 2 Cl 2 (2 ml) was added MsCl (0.28 ml, 3.62 mmol) . After the reaction mixture was stirred at room temperature for 1.5 h, H 2 O and CH 2 Cl 2 were added. The organic solution was separated, washed with brine, and dried (Na 2 SO 4 ). After concentration, the residue was applied to silica gel column chromatography (EtOAc/ hexane = 1/7) to give unstable mesylate (0.82 g, 3.11 mmol, 96%) as a colorless oil. A reaction solution of mesylate (0.82 g, 3.11 mmol) , Ph 3 P (0.90 g, 3.43 mmol), and H 2 O (0.4 ml) in THF (40 ml) was stirred at 50 C for 60 h before additions of 1 M aq. HCl solution and ether. To the aqueous solution was added 3 M aq. NaOH solution. The resulting alkaline aqueous solution was extracted with ether, and then the ether solution was treated with 1 M aq. HCl solution. The acidic aqueous solution was concentrated. To an icecooled mixture of the residue in THF (5 ml) and 2 M aq. K 2 CO 3 solution (4 ml) was added CbzCl (0.57 ml, 3.99 mmol). The reaction mixture was stirred at room temperature for 15 h before additions of 10% aq. NaHSO 4 solution and EtOAc. The organic solution was separated, washed with sat. aq. NaHCO 3 solution and brine, and dried (Na 2 SO 4 ). After concentration, the residue was purified with silica gel column chromatography (2% EtOAc in hexane) to give (2S,6R)-24 (0.38 m, ArH) . NMR C (CDCl 3 ): 14. 1, 20.6, 27.4, 30.3, 37.3, 46.1, 50.5, 66.8, 127.8, 128.4, 137.2, 155.9. 
